Dr. Mark Hyman
👤 PersonAppearances Over Time
Podcast Appearances
I'm not saying it's a be all and end all, but I'm saying it's a very inexpensive first level. So now we have this clinical observation trial that we're doing with a whole variety of people, including pediatric patients,
I'm not saying it's a be all and end all, but I'm saying it's a very inexpensive first level. So now we have this clinical observation trial that we're doing with a whole variety of people, including pediatric patients,
I'm not saying it's a be all and end all, but I'm saying it's a very inexpensive first level. So now we have this clinical observation trial that we're doing with a whole variety of people, including pediatric patients,
with a group of docs that are willing to participate with us in looking at clinically how the inflammatory and immune inflammatory index can be used in their practice for designing personalized intervention. So this is where we're going. This is like a first level beachhead. It's very simple.
with a group of docs that are willing to participate with us in looking at clinically how the inflammatory and immune inflammatory index can be used in their practice for designing personalized intervention. So this is where we're going. This is like a first level beachhead. It's very simple.
with a group of docs that are willing to participate with us in looking at clinically how the inflammatory and immune inflammatory index can be used in their practice for designing personalized intervention. So this is where we're going. This is like a first level beachhead. It's very simple.
So there's a panel of the following. The majority of collisions can have access to that are standard reimbursable analytes. The first, as I mentioned, is a complete blood count with differential. Which measures your... Your red cells and then your white cells. What type of white cells?
So there's a panel of the following. The majority of collisions can have access to that are standard reimbursable analytes. The first, as I mentioned, is a complete blood count with differential. Which measures your... Your red cells and then your white cells. What type of white cells?
So there's a panel of the following. The majority of collisions can have access to that are standard reimbursable analytes. The first, as I mentioned, is a complete blood count with differential. Which measures your... Your red cells and then your white cells. What type of white cells?
And you put it into this little equation.
And you put it into this little equation.
And you put it into this little equation.
The second is secretory IgA, which is measured in your saliva.
The second is secretory IgA, which is measured in your saliva.
The second is secretory IgA, which is measured in your saliva.
So that infers aspects of your mucosal immunity, that first line of defense on your mucosal membranes that protect you against stuff getting into your body and creating mischief.
So that infers aspects of your mucosal immunity, that first line of defense on your mucosal membranes that protect you against stuff getting into your body and creating mischief.
So that infers aspects of your mucosal immunity, that first line of defense on your mucosal membranes that protect you against stuff getting into your body and creating mischief.
It can be done there as well. That's correct. Then the third is the, you've talked about it a lot. In fact, you mentioned Paul Ritker, who was a developer and promoter of high sensitivity CRP, C-reactive protein. C-reactive protein is a molecule made by your body's immune system or actually by the hepatocytes. That then is related to inflammatory burden.
It can be done there as well. That's correct. Then the third is the, you've talked about it a lot. In fact, you mentioned Paul Ritker, who was a developer and promoter of high sensitivity CRP, C-reactive protein. C-reactive protein is a molecule made by your body's immune system or actually by the hepatocytes. That then is related to inflammatory burden.